Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates
Serge Ducommun(École Polytechnique Fédérale de Lausanne), Kei Sakamoto(University of Copenhagen)
Cited by 29
Related Papers
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
|Nature Medicine|2018|324
Motif affinity and mass spectrometry proteomic approach for the discovery of cellular AMPK targets: Identification of mitochondrial fission factor as a new AMPK substrate
|Cellular Signalling|2015|171
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
|Nature Communications|2014|163
Molecular Mechanism by Which AMP-Activated Protein Kinase Activation Promotes Glycogen Accumulation in Muscle
|Diabetes|2011|151
Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965
|Biochemical Journal|2021|46